8 terminated. 8 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 8 | Terminated 8 |
| Phase 2 | 3 | Terminated 3 |
Follow Disease: new trials by email Literature Review of Disease trials Research Report on Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Siplizumab for Sickle Cell Disease Transplant Siplizumab, Exchange Transfusion, Total Body Irradiation - Anemia, Sickle Cell | Phase 1 / Phase 2 | Terminated | Columbia University | 1 | 2023-09-28 | 2026-06-10 |
| A Study of ANV419 Alone or in Combination With Approved Treatments in Patients With Multiple Myeloma (OMNIA-2) ANV419, Lenalidomide with low-dose dexamethasone, Daratumumab - Multiple Myeloma, Relapsed Cancer | Phase 1 | Terminated | Anaveon AG | 4 | 2023-02-10 | 2024-02-12 |
| First-in-Human (FIH) Trial of 1A46 in Subjects with Advanced CD20 And/or CD19 Positive B-cell Hematologic Malignancies 1A46 Injection - Non-Hodgkin's Lymphoma (disorder), Acute Lymphoid Leukemia, Disease (disorder) | Phase 1 / Phase 2 | Terminated | Chimagen Biosciences, Ltd | 7 | 2022-08-30 | 2025-02-13 |
| Treatment of Eosinophilic Chronic Rhinosinusitis Utilizing Betamethasone Dipropionate Nasal Cream Betamethasone Dipropionate Nasal Cream 0.0644%, Pre-filled syringe and applicator device - Chronic Rhinosinusitis (Diagnosis) | Phase 1 / Phase 2 | Terminated | Oticara Australia PTY LTD | 2 | 2022-02-23 | 2024-05-02 |
| Idelalisib Post Allogeneic Hematopoietic Stem Cell Transplant (HSCT) in B Cell Derived Malignancies Idelalisib 100 MG, Placebo Oral Tablet - B Cells-Tumors, B Cell Chronic Lymphocytic Leukemia | Phase 1 | Terminated | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 16 | 2018-07-31 | 2024-03-12 |
| 68Ga-Dotatoc Positron Emission Tomography (PET) for Somatostatin Receptor-Positive Neuroendocrine Tumors (NETs) 68Ga-DOTATOC PET - Neuroendocrine Tumors, Carcinoid Tumors | Phase 1 | Terminated | Lale Kostakoglu | 71 | 2014-12-01 | 2017-05-03 |
| A Pilot Study of 18F-FLT in Pediatric Patients With Central Nervous System (CNS) Tumors 18F-FLT, PET Imaging - Tumors of the Central Nervous System | Phase 1 | Terminated | Dana-Farber Cancer Institute | 2 | 2008-03-01 | 2021-10-20 |
| Study of Immunotoxin, MR1-1 MR1-1 - Supratentorial Malignant Brain Tumor | Phase 1 | Terminated | Darell D. Bigner, MD, PhD | 9 | 2006-11-01 | 2015-03-20 |
Anemia, Sickle Cell (1) · Astrocytoma (1) · Brain Neoplasms (1) · Carcinoid Tumor (1) · Central Nervous System Neoplasms (1) · Ependymoma (1) · Hematologic Diseases (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Lymphoma, Follicular (1) · Lymphoma, Mantle-Cell (1) · Lymphoma, Non-Hodgkin (1) · Multiple Myeloma (1) · Neoplasms (1) · Neuroendocrine Tumors (1)
Pathologic Processes (8) · Pathological Conditions, Signs and Symptoms (8) · Neoplasms (5) · Neoplasms by Histologic Type (5) · Hemic and Lymphatic Diseases (4) · Hematologic Diseases (3) · Immune System Diseases (3) · Immunoproliferative Disorders (3) · Lymphoproliferative Disorders (3) · Disease Attributes (2) · Leukemia (2) · Leukemia, Lymphoid (2) · Lymphatic Diseases (2) · Lymphoma (2) · Neoplasms by Site (2)
Biosimilar Pharmaceuticals (1) · Cyclophosphamide (1) · Dexamethasone (1) · Exchange Transfusion, Whole Blood (1) · Ga(III)-DOTATOC (1) · Lenalidomide (1) · Magnetic Resonance Spectroscopy (1) · Mesna (1) · Rituximab (1) · Sirolimus (1) · Whole-Body Irradiation (1) · alovudine (1) · daratumumab (1) · idelalisib (1) · siplizumab (1)
Anaveon AG (1) · Chimagen Biosciences, Ltd (1) · Columbia University (1) · Dana-Farber Cancer Institute (1) · Darell D. Bigner, MD, PhD (1) · Lale Kostakoglu (1) · Oticara Australia PTY LTD (1) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)
United States (6) · Australia (1) · Denmark (1) · France (1) · Germany (1) · Spain (1) · Switzerland (1)
Annick Desjardins, MD (1) · Douglas Gladstone, MD (1) · Eduard Gasal, MD (1) · Lale Kostakoglu, MD, MPH (1) · Mark Kieran, MD (1) · Markus Y Mapara, MD, PhD (1)
P50NS020023 (1)